Balance Sheet: Liabilities and Stockholders’ Equity

The balance sheet provides creditors, investors, and analysts with information on company resources (assets) and its sources of capital (its equity and liabilities). It normally also provides information about the future earnings capacity of a company assets as well as an indication of cash flows that may come from receivables and inventories.

Liabilities represents obligations of a company arising from past events, the settlement of which is expected to result in an outflow of economic benefits from the entity.

AstraZeneca PLC, consolidated balance sheet: liabilities and stockholders’ equity

US$ in millions

	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012	Dec 31, 2011	Dec 31, 2010
Current interest-bearing loans and borrowings	2,446)	1,788)	901)	1,990)	125)
Trade payables	3,492)	2,499)	2,449)	2,155)	2,257)
Value added and payroll taxes and social security	201)	207)	231)	343)	323)
Rebates and chargebacks	3,530)	2,853)	2,486)	3,285)	2,839)
Accruals	3,231)	3,606)	3,200)	2,474)	2,297)
Other payables	1,432)	1,197)	855)	718)	945)
Trade and other payables	11,886)	10,362)	9,221)	8,975)	8,661)
Derivative financial instruments	21)	2)	3)	9)	8)
Provisions	623)	823)	916)	1,388)	1,095)
Income tax payable	2,354)	3,076)	2,862)	3,390)	6,898)
Current liabilities	17,330)	16,051)	13,903)	15,752)	16,787)
Non-current interest-bearing loans and borrowings	8,397)	8,588)	9,409)	7,338)	9,097)
Derivative financial instruments	—)	1)	—)	—)	—)
Deferred tax liabilities	1,796)	2,827)	2,576)	2,735)	3,145)
Retirement benefit obligations	2,951)	2,261)	2,265)	2,674)	2,472)
Provisions	484)	566)	428)	474)	843)
Accruals	219)	126)	710)	113)	104)
Other payables	7,772)	2,226)	291)	272)	269)
Trade and other payables	7,991)	2,352)	1,001)	385)	373)
Non-current liabilities	21,619)	16,595)	15,679)	13,606)	15,930)
Total liabilities	38,949)	32,646)	29,582)	29,358)	32,717)
Share capital	316)	315)	312)	323)	352)
Share premium account	4,261)	3,983)	3,504)	3,078)	2,672)
Capital redemption reserve	153)	153)	153)	139)	107)
Merger reserve	448)	433)	433)	433)	433)
Other reserves	1,420)	1,380)	1,374)	1,379)	1,377)
Retained earnings	13,029)	16,960)	17,961)	17,894)	18,272)
Capital and reserves attributable to equity holders of the Company	19,627)	23,224)	23,737)	23,246)	23,213)
Non-controlling interests	19)	29)	215)	226)	197)
Total equity	19,646)	23,253)	23,952)	23,472)	23,410)
Total liabilities and equity	58,595)	55,899)	53,534)	52,830)	56,127)

Based on: 20-F (reporting date: 2014-12-31), 20-F (reporting date: 2013-12-31), 20-F (reporting date: 2012-12-31), 20-F (reporting date: 2011-12-31), 20-F (reporting date: 2010-12-31).

Download chart

Balance sheet item	Description	The company
Current liabilities	Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.	AstraZeneca PLC current liabilities increased from 2012 to 2013 and from 2013 to 2014.
Non-current liabilities	Amount of obligation due after one year or beyond the normal operating cycle, if longer.	AstraZeneca PLC non-current liabilities increased from 2012 to 2013 and from 2013 to 2014.
Total liabilities	Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.	AstraZeneca PLC total liabilities increased from 2012 to 2013 and from 2013 to 2014.
Capital and reserves attributable to equity holders of the Company	Total of all stockholders’ equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity stockholders’ equity attributable to the parent excludes the amount of stockholders’ equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.	AstraZeneca PLC capital and reserves attributable to equity holders of the Company decreased from 2012 to 2013 and from 2013 to 2014.

AstraZeneca PLC (NYSE:AZN)

Balance Sheet: Liabilities and Stockholders’ Equity